Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001377059 | SCV001574289 | likely pathogenic | Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S | 2020-03-19 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exon 6 of the IGHMBP2 gene. It preserves the integrity of the reading frame. This variant has not been reported in the literature in individuals with IGHMBP2-related conditions. This variant disrupts the p.Arg264 amino acid residue in IGHMBP2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26392352; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |